Business
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence
BAAR, Switzerland, February 09, 2026--Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence
About this update from Bristol-myers Squibb Company
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1858,"height":417,"url":"https://media.zenfs.com/en/business-wire.com/4d2e1496798a9683f9ff6f798b89c932"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Rtj_qKfD5_wIXM9sxokjWA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIxNTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/4d2e1496798a9683f9ff6f798b89c932","width":960,"height":215},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/tTKWkSb3v3oLx1UpTeiKSA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01Mzg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/4d2e1496798a9683f9ff6f798b89c932","width":1200,"height":269}},"lazy":false},{"type":"text","content":"Agreement will leverage Evinova’s innovative AI-native platform to improve trial design, accelerate timelines, and enhance cost efficiency","length":138,"tagName":"p"},{"type":"text","content":"BAAR, Switzerland, February 09, 2026--(BUSINESS WIRE)--Evinova today announced that Bristol Myers Squibb has signed an agreement to optimize clinical trials with Evinova’s AI-native clinical development platform. Under the terms of the agreement, Bristol Myers Squibb will deploy the Cost Optimizer module of Evinova’s Study Designer across the company’s global portfolio, harnessing advanced artificial intelligence to improve insight-driven decision making, identify productivity opportunities, and unlock more efficient trial designs that accelerate innovation and improve experience for sites and patients.","length":610,"tagName":"p"},{"type":"text","content":""Drug development is changing rapidly, and life science companies need partners who bring both AI leadership and clinical development expertise to successfully drive transformation," said Cristina Duran, President of Evinova. "Evinova, founded by pharma for pharma, combines AI innovation with deep industry insight to reimagine clinical development. We’re thrilled to collaborate with Bristol Myers Squibb to drive efficiencies in drug development and accelerate breakthroughs for patients."","length":512,"tagName":"p"},{"type":"text","content":""Transforming clinical development is not just an opportunity; it is an urgent necessity," said Cristian Massacesi, MD, EVP, Chief Medical Officer & Head of Development at Bristol Myer...